Видео ютуба по тегу Breast Cancer Symposium

Образование, расширение прав и возможностей и профилактика рака молочной железы: защита интересов...
Образование, расширение прав и возможностей и профилактика рака молочной железы: защита интересов...
Enhertu moving to first-line therapy of metastatic HER2+ breast cancer.
Enhertu moving to first-line therapy of metastatic HER2+ breast cancer.
3rd International Conference on Cancer and Breast Cancer Treatment| Webinar 2025 | Part 2
3rd International Conference on Cancer and Breast Cancer Treatment| Webinar 2025 | Part 2
3rd International Conference on Cancer and Breast Cancer Treatment| Webinar 2025 | Part 1
3rd International Conference on Cancer and Breast Cancer Treatment| Webinar 2025 | Part 1
Welcome Prof. Beat Thürlimann | Medical Oncology | Best of St. Gallen India 2026
Welcome Prof. Beat Thürlimann | Medical Oncology | Best of St. Gallen India 2026
Is T-DXd Rewriting First-Line HER2+ Metastatic Breast Cancer? - Dr. Mark Pegram & Dr. Fengting Yan
Is T-DXd Rewriting First-Line HER2+ Metastatic Breast Cancer? - Dr. Mark Pegram & Dr. Fengting Yan
Is Hormone Therapy Safe? 🩺 #womenshealth
Is Hormone Therapy Safe? 🩺 #womenshealth
Early Bird Registration Open | Best of 19th St. Gallen Breast Cancer Conference India 2026
Early Bird Registration Open | Best of 19th St. Gallen Breast Cancer Conference India 2026
Почему онкологи в восторге от этих новых клинических испытаний методов лечения рака груди #Исслед...
Почему онкологи в восторге от этих новых клинических испытаний методов лечения рака груди #Исслед...
Breast Cancer Awareness Workshop | Screening & Patient Care | Best of St. Gallen India 2026
Breast Cancer Awareness Workshop | Screening & Patient Care | Best of St. Gallen India 2026
Genetics of Breast Cancer Workshop | Best of 19th St. Gallen Conference 2026 | India
Genetics of Breast Cancer Workshop | Best of 19th St. Gallen Conference 2026 | India
3 Breast Cancer Trials That Will Change Care in 2026
3 Breast Cancer Trials That Will Change Care in 2026
Новые терапевтические подходы при HER2-позитивном и трижды негативном раке молочной железы
Новые терапевтические подходы при HER2-позитивном и трижды негативном раке молочной железы
Интеграция сацитузумаба и пембролизумаба в лечение рака молочной железы
Интеграция сацитузумаба и пембролизумаба в лечение рака молочной железы
Real-world outcomes with 1L regimens in HER2+ metastatic breast cancer
Real-world outcomes with 1L regimens in HER2+ metastatic breast cancer
Age at diagnosis and outcomes in young BRCA-associated breast cancer
Age at diagnosis and outcomes in young BRCA-associated breast cancer
Real-world outcomes challenge sequential TOP1-ADCs in HER2-low breast cancer
Real-world outcomes challenge sequential TOP1-ADCs in HER2-low breast cancer
Awards & Research Grants | Best of 19th St. Gallen Breast Cancer Conference India 2026
Awards & Research Grants | Best of 19th St. Gallen Breast Cancer Conference India 2026
From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
New year ,new breast cancer guidelines…before drinking this new year…read this !
New year ,new breast cancer guidelines…before drinking this new year…read this !
Scientific Committee | Best of 19th St. Gallen Breast Cancer Conference India 2026
Scientific Committee | Best of 19th St. Gallen Breast Cancer Conference India 2026
Reception Committee | Best of 19th St. Gallen International Breast Cancer Conference India 2026
Reception Committee | Best of 19th St. Gallen International Breast Cancer Conference India 2026
Развитие адъювантной терапии: ингибиторы CDK4/6 при раке молочной железы на ранних стадиях
Развитие адъювантной терапии: ингибиторы CDK4/6 при раке молочной железы на ранних стадиях
3rd Deep Dive into Advances in Breast Cancer – Clinical Updates from SABCS & ESMO 2025 | 18th Dec
3rd Deep Dive into Advances in Breast Cancer – Clinical Updates from SABCS & ESMO 2025 | 18th Dec